tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Dominic Lunn, 7 are a HOLD (53.85%), 3 are a SELL (23.08%), 3 are a BUY (23.08%).
Analyst Dominic Lunn, currently employed at CREDIT SUISSE, carries an average stock price target met ratio of 40% that have a potential upside of 5.31% achieved within 59 days.
Dominic Lunn’s has documented 25 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVO, Novo Nordisk A/S at 03-Nov-2022.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 8/23/2021. The price target of $49.37 was fulfilled within 8 days with a profit of $2.31 (4.47%) receiving and performance score of 5.59.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
5 days ago
(15-Nov-2024)
0/13 (0%)
$-19.36 (-47.20%)
Buy
$39.5
$5.11 (14.86%)
$53
8 days ago
(12-Nov-2024)
2/5 (40%)
$4 (11.27%)
368
Buy
$22.07
4 months 12 days ago
(08-Jul-2024)
0/14 (0%)
$-16.41 (-42.65%)
Hold
$44
$9.61 (27.94%)
$18.72
9 months 28 days ago
(23-Jan-2024)
1/14 (7.14%)
$5.42 (14.05%)
107
Hold
$19.52
$-14.87 (-43.24%)
$18.9
1 years 3 months 6 days ago
(14-Aug-2023)
0/3 (0%)
$-14.59 (-42.77%)
What Year was the first public recommendation made by Dominic Lunn?
